Jing Pengwei, Song Xiaoying, Xiong Lirong, Wang Biyao, Wang Yaping, Wang Lu
Laboratory of Stem Cells and Tissue Engineering, Chongqing Medical University, 1 Yixueyuan Road, Yuzhong District, 400016, Chongqing, China.
The People's Hospital of Jiajiang, 614100, Leshan, China.
Mol Biol Rep. 2023 Jan;50(1):121-132. doi: 10.1007/s11033-022-07898-w. Epub 2022 Oct 31.
Extrinsic molecular mechanisms that regulate hematopoietic stem/progenitor cell (HSPC) aging are still poorly understood, and a potential protective medication needs to be explored.
The senescent parameters of hematopoietic cells and bone marrow stromal cells (BMSCs) including cell cycle analysis, senescence-associated SA-β-gal staining and signals, hematopoietic factors and cellular junction were analyzed in femur and tibia of rats. Furthermore, Sca-1 HSPCs and BMSCs co-culture system was established to evaluate the direct effects of BMSC feeder layer to HSPCs. Oxidative DNA damage indicators in Sca-1 HSCs and senescence-associated secretory phenotype (SASP) of BMSCs, gap junction intercellular communication between BMSCs, osteogenesis/adipogenisis differentiation balance of BMSCs were detected.
In the D-gal pre-administrated rats, ASP treatment rescued senescence of hematopoietic cells and BMSCs, reserved CFU-GEMM; also, ASP treatment attenuated stromal oxidative load, ameliorated SCF, CXCL12, and GM-CSF production, increased Connexin-43 (Cx43) expression. BMSCs and Sca-1 HSPCs co-cultivation demonstrated that ASP treatment prevented oxidative DNA damage response in co-cultured Sca-1 HSPCs induced by D-gal pre-administration of feeder layer and the underlying mechanism may be related to ASP ameliorating feeder layer dysfunction due to D-gal induced senescence via inhibiting secretion of IL-1, IL-6, TNF-α, and RANTES, enhancing Cx43-mediated intercellular communication, improving Runx2 expression whereas decreasing PPARγ expression in BMSCs.
The antioxidant property of ASP may provide a stroma-mediated potential therapeutic strategy for HSPC aging.
调节造血干/祖细胞(HSPC)衰老的外在分子机制仍知之甚少,需要探索一种潜在的保护性药物。
分析大鼠股骨和胫骨中造血细胞和骨髓基质细胞(BMSC)的衰老参数,包括细胞周期分析、衰老相关的SA-β-半乳糖苷酶染色及信号、造血因子和细胞连接。此外,建立Sca-1 HSPC与BMSC共培养系统,以评估BMSC饲养层对HSPC的直接作用。检测Sca-1造血干细胞中的氧化DNA损伤指标、BMSC的衰老相关分泌表型(SASP)、BMSC之间的间隙连接细胞间通讯、BMSC的成骨/成脂分化平衡。
在预先给予D-半乳糖的大鼠中,ASP治疗可挽救造血细胞和BMSC的衰老,保留CFU-GEMM;此外,ASP治疗可减轻基质氧化负荷,改善SCF、CXCL12和GM-CSF的产生,增加连接蛋白-43(Cx43)的表达。BMSC与Sca-1 HSPC共培养表明,ASP治疗可预防预先给予D-半乳糖的饲养层诱导的共培养Sca-1 HSPC中的氧化DNA损伤反应,其潜在机制可能与ASP通过抑制IL-1、IL-6、TNF-α和RANTES的分泌改善D-半乳糖诱导的衰老引起的饲养层功能障碍、增强Cx43介导的细胞间通讯、提高Runx2表达而降低BMSC中PPARγ表达有关。
ASP的抗氧化特性可能为HSPC衰老提供一种基质介导的潜在治疗策略。